Simplify Logo

Full-Time

Regional Medical Lead

Southeast

Posted on 7/6/2024

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Biotechnology
Healthcare

Compensation Overview

$180k - $220kAnnually

+ Cash Bonus + Stock Options

Senior

Orlando, FL, USA + 3 more

More locations: Miami, FL, USA | Raleigh, NC, USA | Durham, NC, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Management
Requirements
  • Coronary artery disease and lipid management expertise
  • Advanced clinical or scientific degree (PharmD, PhD, or MD/DO, MS, PA, ARNP) preferred
  • Minimum of 5 years of Cardiovascular experience, experience in lipid management ideal
  • Experience in pharma, biotech and/or medical devices, ideally as a medical science liaison (MSL)
  • Significant direct experience communicating complex scientific information
  • Advanced presentation and computer skills with expertise in literature identification and evaluation
  • Significant travel (~50% of time) both by automobile and air
Responsibilities
  • Establish and foster professional relationships with national and regional Key Opinion Leaders (KOLs) in lipid management and preventive cardiology and with internal business partners
  • Support the identification and training of educational faculty
  • Serve as a key HeartFlow scientific resource in the field, supporting HCP education including advanced data and case reviews
  • Gather feedback and insights from KOLs and physician advisors to better inform HeartFlow’s overall strategic direction
  • Identify and support regional education opportunities
  • In collaboration with the Clinical team at HeartFlow, facilitate initial discussions, intake, and evaluation of physician-initiated research proposals
  • Understand and effectively communicate current scientific knowledge, maintaining expertise through keeping up to date with publications and attendance of national and local congresses
  • Monitor major meetings for abstract deadlines and work with investigators of HeartFlow sponsored research to drive podium presence in support of corporate communication strategies and plan
  • Support field and internal training needs as a clinical expert

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company's product offerings include the HeartFlow Analysis, which consists of various analyses like FFRCT, RoadMap, and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries including the US, UK, Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning and patient safety. The goal of HeartFlow is to improve cardiovascular care by providing advanced diagnostic tools that facilitate better treatment decisions.

Company Stage

Series F

Total Funding

$1.2B

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

6%

1 year growth

16%

2 year growth

19%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $215 million Series F funding round led by Bain Capital Life Sciences positions HeartFlow for significant growth and expansion.
  • HeartFlow's AI-enabled products, such as the RoadMap Analysis, enhance diagnostic accuracy and efficiency, potentially improving patient outcomes and physician workflows.
  • With coverage by 100% of Medicare and over 98% of commercial payers, HeartFlow's technology is widely accessible, increasing its adoption and market penetration.

What critics are saying

  • The cardiovascular care market is highly competitive, requiring continuous innovation to maintain a leading position.
  • Regulatory hurdles and the need for ongoing FDA clearances could delay product launches and market entry.

What makes HeartFlow unique

  • HeartFlow's non-invasive cardiac test offers a safer and more efficient alternative to traditional invasive procedures, setting it apart in the cardiovascular care market.
  • The company's comprehensive product portfolio, including FFRCT, RoadMap, and Plaque Analysis, provides a unique combination of anatomical and physiological visualization of coronary arteries.
  • HeartFlow's technology has received FDA clearance and is commercially available in multiple countries, ensuring a broad market reach and regulatory credibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE